https://sites.lifesci.ucla.edu/mbi-home/wp-content/uploads/sites/191/2015/08/UCL_MBI_logo_40.gif
0
0
galkin2
https://sites.lifesci.ucla.edu/mbi-home/wp-content/uploads/sites/191/2015/08/UCL_MBI_logo_40.gif
galkin22015-09-18 10:29:262015-09-18 10:29:26BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90.
Stabilizing membrane proteins. Solving the membrane protein folding problem.
Scroll to top
